Efficacy of yoga, tai chi and qi gong on the main symptoms of chronic obstructive pulmonary disease: A systematic review.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
May 2019
Historique:
received: 22 01 2019
revised: 19 03 2019
accepted: 08 04 2019
pubmed: 27 6 2019
medline: 16 1 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

The aim of this systematic review was to summarize the effects of yoga, qi gong or tai chi in COPD patients. Studies evaluating effects of the selected complementary therapies on lung function, dyspnea, quality of life or functional exercise capacity in COPD patients were identified and reviewed from three databases. Eighteen studies were included. Six studies evaluated the effects of yoga and the others focused on tai chi or qi gong separately or combined. The duration of the programs ranged from 6 weeks to 6 months and the frequency from 2 to 7 times a week. Each session reached 30 to 90 minutes. Benefits were observed on lung function and functional exercise capacity but benefit was clearly stated neither on quality of life nor on dyspnea. This systematic review highlights the potential of these therapies as complementary therapeutic approach in COPD patients.

Identifiants

pubmed: 31235453
pii: S2590-0412(19)30005-4
doi: 10.1016/j.resmer.2019.04.002
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-25

Informations de copyright

Copyright © 2019 SPLF and Elsevier Masson SAS. All rights reserved.

Auteurs

G Reychler (G)

Institut de recherche expérimentale et clinique (irec), pôle de pneumologie, ORL & dermatologie, université Catholique de Louvain, Brussels, Belgium; Service de pneumologie, cliniques universitaires Saint-Luc, Brussels, Belgium; Haute école Leonard de Vinci-institut d'enseignement supérieur Parnasse-Deux Alice, Brussels, Belgium. Electronic address: gregory.reychler@uclouvain.be.

W Poncin (W)

Institut de recherche expérimentale et clinique (irec), pôle de pneumologie, ORL & dermatologie, université Catholique de Louvain, Brussels, Belgium; Service de pneumologie, cliniques universitaires Saint-Luc, Brussels, Belgium. Electronic address: William.poncin@uclouvain.be.

S Montigny (S)

Haute école Leonard de Vinci-institut d'enseignement supérieur Parnasse-Deux Alice, Brussels, Belgium. Electronic address: montigny.sophie@wanadoo.fr.

A Luts (A)

Département de psychiatrie adulte, cliniques universitaires Saint Luc, Brussels, Belgium. Electronic address: alain.luts@uclouvain.be.

G Caty (G)

Service de médecine physique et réadaptation, cliniques universitaires Saint-Luc, Brussels, Belgium. Electronic address: gilles.caty@uclouvain.be.

T Pieters (T)

Institut de recherche expérimentale et clinique (irec), pôle de pneumologie, ORL & dermatologie, université Catholique de Louvain, Brussels, Belgium; Service de pneumologie, cliniques universitaires Saint-Luc, Brussels, Belgium. Electronic address: thierry.pieters@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH